$11.160
-0.470 (-4.21%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
NTLA 相似图表分析预测
Alphio's NTLA stock price prediction model matches the current Intellia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.25 (+0.84%). The 1-week path is $11.29 (+1.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Intellia Therapeutics Inc 股票吗？
Intellia Therapeutics is not a good buy right now due to significant financial losses and analyst concerns. The current price is $11.42, which is above Barclays' price target of $8, indicating a potential downside of 30%. Additionally, the RSI is at 36.2, suggesting the stock is oversold but lacks momentum for a recovery. The company is facing regulatory challenges and insider selling has increased by 2235.78%, raising red flags about future performance.
NTLA 股价于 Thursday 收于 $11.16，此前下跌 -4.21%
Intellia Therapeutics Inc (NTLA) last closed at $11.16, losing -4.21%. These facts feed the 1-day and 1-week NTLA price prediction above.
分析师一致预期
Intellia Therapeutics Inc（NTLA）：买入 4、持有 2、卖出 0。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Intellia Therapeutics Inc（NTLA）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 NTLA 最接近的股票，按相似度排序。
NTLA 季节性分析
Historically the probability of a positive October return for NTLA is 62.90%. October offers the highest probability of a positive month at 62.90%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。